COVID-19 vaccine winners suffer reversal of fortune
Pharma companies have yet to provide investors with convincing post-pandemic strategies At the height of the pandemic, investors clamoured to buy vaccine makers, the closest thing to a sure bet. But the fall in coronavirus infections has meant...